Skip to Main Content

Paper Details

Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Clin Cancer Res
1
2023
Author NameAffiliation
Dexiang GaoUniversity of Colorado Denver-Anschutz Medical Center
  • 1 - 1

Datasets

Release 1.2